MTOR and Alzheimer disease: In a mouse model for Alzheimer’s disease, exogenous interferon-γ (IFN-γ) attenuated neurological deficits by attenuating the stimulation of β amyloid to microglia through promoting glycolysis by activating mTOR pathway (33).